Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.
WuXi AppTec Co., Ltd. announced the completion of its 2025 Second Share Repurchase Plan, which involved repurchasing and canceling A shares to safeguard company value and shareholder interests. The plan, which utilized RMB1 billion in funds, was executed without deviation from its original disclosure and will not materially impact the company’s operations, financials, or listing status.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company focuses on providing comprehensive and integrated services across the drug development process, including research, development, and manufacturing solutions.
Average Trading Volume: 8,289,767
Technical Sentiment Signal: Buy
Current Market Cap: HK$202.3B
Learn more about 2359 stock on TipRanks’ Stock Analysis page.